A novel real-time RT-PCR assay for quantification of OTT-MAL fusion transcript reliable for diagnosis of t(1;22) and minimal residual disease (MRD) detection.
Ballerini
P
P
Blaise
A
A
Mercher
T
T
Pellegrino
B
B
Perot
C
C
van den Akker
J
J
Gatbois
E
E
Adam
M
M
Douay
L
L
Berger
R
R
Bernard
O
O
Landman-Parker
J
J
D000208:Acute Disease; D015703:Antigens, CD / Q000032:analysis; D002675:Child, Preschool; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics*; D002892:Chromosomes, Human, Pair 22 / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000235:genetics*; D006801:Humans; D007951:Leukemia, Myeloid / Q000175:diagnosis* / Q000235:genetics; D018365:Neoplasm, Residual; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D011506:Proteins / Q000235:genetics*; D016601:RNA-Binding Proteins; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D012680:Sensitivity and Specificity; D015534:Trans-Activators; D014178:Translocation, Genetic
D015703:Antigens, CD; D004268:DNA-Binding Proteins; C431575:MRTFA protein, human; D015514:Oncogene Proteins, Fusion; D011506:Proteins; C431574:RBM15 protein, human; D016601:RNA-Binding Proteins; D015534:Trans-Activators